Highly active antiretroviral therapy and viral response in HIV type 2 infection.

@article{Mullins2004HighlyAA,
  title={Highly active antiretroviral therapy and viral response in HIV type 2 infection.},
  author={Christopher B. Mullins and Geoffrey Eisen and Stephen J Popper and Abdoulaye Dieng Sarr and J Louis Sankale and Judith J Berger and Sharon B. Wright and Hernan R. Chang and Gerard Coste and Timothy P. Cooley and Peter S Rice and Paul R. Skolnik and Margaret W Sullivan and Phyllis J Kanki},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2004},
  volume={38 12},
  pages={
          1771-9
        }
}
Human immunodeficiency virus type 2 (HIV-2), the second human retrovirus known to cause AIDS, is endemic to West Africa but is infrequently found outside this region. We present a case series of 10 HIV-2--infected individuals treated in the United States. Physicians applied the principles of highly active antiretroviral therapy (HAART), normally used in treating HIV type 1, with modifications considered appropriate for treating HIV-2. CD4+ cell count, HIV-2 virus load, and clinical status were… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 22 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 37 REFERENCES

Antiviral resistance of biologic HIV-2 clones obtained from individuals on nucleoside reverse transcriptase inhibitor therapy

  • ME vanderEnde
  • J Acquir Immune Defic Syndr
  • 2000
1 Excerpt

Similar Papers

Loading similar papers…